Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ATP-sensitive potassium (KATP) channel is a type of potassium ion channel that links cellular metabolism to membrane excitability. It is widely distributed in various tissues, including muscle, pancreatic beta cells, the brain, and the cardiovascular system. The activity of KATP channels is regulated by intracellular levels of adenine nucleotides—primarily ATP and ADP—allowing these channels to act as metabolic sensors within cells. The KATP channel is an octameric complex composed of four pore-forming Kir6.x subunits (inwardly rectifying potassium channels; isoforms include Kir6.1 and Kir6.2) and four regulatory sulfonylurea receptor (SURx) subunits (members of the ABC transporter family). Intracellular ATP binds directly to sites on the Kir6.x subunit, causing closure of the channel. In the presence of Mg²⁺, ADP can bind to SURx and stimulate opening. Mutations in genes encoding either Kir6.x or SURx can cause congenital hyperinsulinism or neonatal diabetes due to dysregulated insulin secretion.
Sulfonylureas bind to SURx subunits, promoting channel closure and stimulating insulin release in pancreatic beta cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium ATP Channel (KATP channel).